Dissolution studies of some sustained-release theophylline dosage forms.

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Pharmacokinetics

Background:

• Sustained-release theophylline formulations are critical for managing respiratory conditions.
• In vitro dissolution profiles are essential predictors of in vivo drug performance and bioavailability.
• Variability in dissolution can lead to therapeutic failures or adverse events.

Purpose of the Study:

• To evaluate the in vitro dissolution characteristics of various sustained-release theophylline products.
• To compare drug release profiles across different brands, strengths, and simulated physiological fluids.
• To correlate in vitro dissolution data with existing in vivo bioavailability and pharmacokinetic studies.

Main Methods:

• Utilized the United States Pharmacopeia (USP) rotating-basket apparatus for dissolution testing.
• Studied nine formulations from four different brands of sustained-release theophylline products.
• Conducted tests in simulated gastric and intestinal fluids at various time points.

Main Results:

• Significant variability in the percentage of theophylline dose released within 1 and 6 hours in gastric fluid.
• Some formulations demonstrated rapid and complete drug release in intestinal fluid within 3-4 hours.
• Observed a dosage form exhibiting apparent zero-order drug release kinetics.
• Dissolution of one theophylline brand in intestinal fluid over 25 hours was notably low (48.1% and 29.9%).
• Rank correlation found between in vitro dissolution results and prior bioavailability/pharmacokinetic data.

Conclusions:

• In vitro dissolution studies highlight significant inter-brand and inter-formulation variability in sustained-release theophylline.
• Dissolution behavior in intestinal fluid suggests potential for premature release in some products.
• The in vitro data provides a valuable basis for understanding in vivo drug performance and optimizing formulation design.